Dare Bioscience Inc (DARE) Financials

$0.75

$-0.07 (-8.54%)

As on 26-Aug-2026 16:24EDT

Market cap

$16 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

29.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1.37	1.03	0.01	2.81	10.00	10.00
Cost of Revenue	2.59	2.45	14.31	21.64	0.05	0.10
Gross Profit	-1.22	-1.42	-14.30	-18.83	10.00	-0.10
Operating Expenses	9.89	12.14	9.16	12.11	41.39	38.97
Operating Profit (EBIT)	-11.11	-13.55	-23.45	-30.94	-31.39	-39.07
Other Income	--	--	--	--	--	--
Profit before Tax	-10.99	-13.40	-4.05	-30.16	-30.95	-38.70
Provision for Tax	--	--	-4,049.55	0.00	-437.75	-0.37
Profit after Tax (Net Income)	-10.99	-13.40	-4.05	-30.16	406.80	-38.70
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-30.95	-38.70

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-0.56	2.84	-6.01	-5.05	11.11	38.75
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.01	5.95	6.50	5.85	1.09	1.00
Current Liabilities	16.92	23.69	21.61	20.48	31.62	16.05
Total Liabilities	39.29	32.47	22.10	21.28	43.83	55.81

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	5.68	5.41	3.65	3.74	0.79	0.51
Current Assets	16.69	27.06	18.45	17.54	43.04	55.30
Total Assets	39.06	32.47	22.10	21.28	43.83	55.81
Total Debt*	6.76	2.66	1.30	1.40	0.49	0.27
Net Current Assets	--	3.38	-3.16	-2.94	11.41	39.24

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.89	5.39	-38.86	-18.09	-28.76
Cash Flow from Investing Activities	--	-0.39	-0.57	-0.63	-0.06	-0.01
Cash from Financing Activities	--	19.28	0.43	15.64	1.34	75.85
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.79	-0.92	-0.48	-4.13	59.81	-8.92
Cash EPS ($)	--	-0.81	-0.47	-4.13	59.81	-8.92
Adjusted Book Value ($)	--	0.20	--	--	1.63	8.94
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.68	0.63	-5.33	-2.66	-6.63
Free Cash Flow per Share ($)	--	-0.71	0.57	-5.41	-2.67	-6.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-3,394.00	97.07	-758.05	1,607.10	-200.34
ROE (%)	--	845.53	73.30	-994.69	1,631.57	-205.82
ROA (%)	-30.84	-49.10	-18.69	-92.65	816.60	-122.15
EBIT Margin (%)	-571.40	-1,220.80	-41,430.90	-1,094.77	-313.85	-386.96
Net Margin (%)	-804.37	-1,300.66	-41,430.90	-1,074.17	4,068.02	-386.96
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	7,816.73	104.29	-1.00	-0.72	--	--
EBIT Growth (%)	57.43	-210.26	86.81	2.06	18.89	-41.22
Net Profit Growth (%)	40.94	-230.55	86.56	-107.41	1,151.27	-41.22
EPS Growth (%)	63.49	-0.94	0.88	-1.07	7.70	-0.04
Book Value Growth (%)	97.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.09	-6.54	-0.07	0.01	-0.22
Price / Book Value	29.40	9.84	-4.41	-0.45	0.51	0.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.06	-0.57	3,906.58	0.22	0.91	1.11
Close Price ($)	2.11	1.93	3.12	3.71	9.96	24.00
High Price ($)	9.19	9.19	7.56	16.80	25.20	46.20
Low Price ($)	1.27	1.61	2.67	3.24	9.84	14.40
Market Cap ($ Cr)	15.89	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.93	-0.22	-0.28	0.04	0.01
Short term debt to equity ratio	-1.35	0.74	-0.09	-0.09	0.04	0.01
Current Ratio	0.99	1.14	0.85	0.86	1.36	3.44
Quick Ratio	0.99	--	--	--	--	157.57
Interest Coverage	-16.73	-15.29	--	--	-0.07	-103.91

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	4.13	55.63	2,350.59	33.81	17.03	11.45
Asset Turnover	0.04	0.04	0.00	0.09	0.20	0.32
Receivable days	--	142.36	22,010.44	172.51	52.02	29.32
Inventory Days	--	--	--	--	-18,978,053.02	-7,901,376.75
Payable days	--	198.25	61.81	45.69	15,843.72	5,705.96
Cash Conversion Cycle	--	--	--	--	-18,993,844.72	-7,907,053.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.